Report Highlights
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015, at a compound annual growth rate (CAGR) of 18.6% over the next 5 years.
SCOPE OF REPORT
This report focuses on global markets for telemedicine technologies and services. The discussion is organized into nine chapters and appendices, as shown below:
- Telemedicine Overview
- Telemedicine Technologies and Markets (including analysis of key patents)
- Telemedicine Services
- Telemedicine Applications
- Economics of Telemedicine
- Opportunities Analysis
- Consolidation and Ownership Trends
- Profiles of Important Players
- Conclusions
- Appendices
- List of Telemedicine Programs Studied
- Allowable Telemedicine Providers and Services for Medicaid Reimbursement
- Medicaid Reimbursement Mechanisms for Telemedicine
- Acronyms
Analyst Credentials
The author of the original report on which this update is based is Sandeep Sugla. Sandeep holds a bachelor’s degree in electronics engineering and has 6 years of research experience in pharmaceuticals, healthcare, medical equipment, and biotechnology.
The analyst responsible for updating the report is Andrew McWilliams, a partner at 43rd Parallel LLC, a Boston-based international technology and marketing consulting firm. Mr. McWilliams is the author of numerous BCC Research studies, including many related to telemedicine, including HLC054B Home Medical Equipment: Technologies and Global Markets, HLC082A Emerging Markets for Advanced Medical Technologies, HLC066A Medical Automation Technologies, Products, and Markets, HLC048B Healthcare Information Technology, and HLC038C Patient Monitoring.
Report Highlights
-
The global market for telemedicine increased from $4.8 billion in 2006 to an estimated $5.8 billion in 2007. It should reach $13.9 billion by 2012, a compound annual growth rate (CAGR) of 19%.
-
The telehome market currently accounts for 22% of the market and is expected to capture almost 37% of the telemedicine market by 2012.
-
The telemedicine service market is expected to grow from $3.6 billion in 2007 to $8.3 billion in 2012, mainly driven by the telehospital service market.
Report Highlights
-
The current level of telemedicine expenditures is about $4.33 billion.
-
These expenditures will experience an AAGR of 9.7% from 2002 to 2007.
-
Procurement will continue to be the lead spending category through 2007.
-
In 2007, it will account for a total of $2.16 billion, or about 31% of all spending.
-
Fastest growth in technology spending will be software, at an AAGR of 12.9%.
Related Reports
Recent Reports
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.
Global Cleanroom Technology Market
The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Microelectromechanical Systems (MEMS) in Global Medical Markets
The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
World Markets for Fermentation Ingredients
The global fermentation-derived fine chemicals market should reach $42.4 billion by 2027 from $32.0 billion in 2022 at a compound annual growth rate (CAGR) of 5.8% for the forecast period of 2022 to 2027.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More